Regulus Therapeutics Inc.
RGLSDelisted Jun 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001505512
Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Regulus Therapeutics Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- −3 vs. Q2 2021
- Shares held
- 23.0M
- −101.8K (−0.4%) vs. Q2 2021
- Total value
- $15.9M
- −$2.88M (−15.4%) vs. Q2 2021
- New holders
- 6
- 8 more added
- Sold out
- 9
- 11 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RGLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 1 | $760 |
| Q1 2025 | 75 | $107.0M |
| Q4 2024 | 69 | $84.5M |
| Q3 2024 | 70 | $89.1M |
| Q2 2024 | 63 | $109.5M |
| Q1 2024 | 45 | $147.3M |
| Q4 2023 | 26 | $14.2M |
| Q3 2023 | 25 | $15.0M |
| Q2 2023 | 26 | $15.0M |
| Q1 2023 | 27 | $6.82M |
| Q4 2022 | 28 | $11.1M |
| Q3 2022 | 25 | $13.8M |
| Q2 2022 | 28 | $12.6M |
| Q1 2022 | 37 | $18.1M |
| Q4 2021 | 38 | $9.54M |
| Q3 2021 | 42 | $15.9M |
| Q2 2021 | 45 | $18.7M |
| Q1 2021 | 44 | $42.6M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Regulus Therapeutics Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Sonora Investment Management, LLC | 16 | $0 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 50 | $0 | 0.00% | +50 | New |
| BlackRock Inc. | 2,320 | $2.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 7,085 | $5.00K | 0.00% | −547−7.2% | Reduced |
| Royal Bank of Canada | 7,063 | $5.00K | 0.00% | 00.0% | Unchanged |
| Community Bank, N.A. | 6,900 | $5.00K | 0.00% | 00.0% | Unchanged |
| AdvisorNet Financial, Inc | 7,500 | $5.00K | 0.00% | +7,500 | New |
| Blair William & Co | 10,700 | $7.00K | 0.00% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 10,610 | $7.00K | 0.00% | 00.0% | Unchanged |
| Dowling & Yahnke LLC | 12,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| WealthTrust Axiom LLC | 13,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 11,900 | $8.00K | 0.00% | +11,900 | New |
| McGuire Investment Group, LLC | 15,000 | $10.0K | 0.00% | −9,000−37.5% | Reduced |
| Creative Planning | 14,200 | $10.0K | 0.00% | 00.0% | Unchanged |
| All Terrain Financial Advisors, LLC | 15,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 14,000 | $10.0K | 0.00% | +14,000 | New |
| UBS Group AG | 19,874 | $14.0K | 0.00% | +19,874 | New |
| Simplex Trading, LLC | 18,323 | $15.0K | 0.00% | −2,000−9.8% | Reduced |
| Citadel Advisors LLC | 35,357 | $24.0K | 0.00% | −244,378−87.4% | Reduced |
| Price T Rowe Associates Inc | 38,100 | $26.0K | 0.00% | +38,100 | New |
| GYL Financial Synergies, LLC | 41,000 | $28.0K | 0.01% | 00.0% | Unchanged |
| Lido Advisors, LLC | 57,500 | $39.0K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 64,708 | $45.0K | 0.00% | −141,557−68.6% | Reduced |
| Grimes & Company, Inc. | 71,671 | $49.0K | 0.00% | +8,409+13.3% | Added |
| Group One Trading, L.P. | 89,077 | $62.0K | 0.00% | −104,484−54.0% | Reduced |
| Commonwealth Equity Services, LLC | 111,000 | $76.0K | 0.00% | +31,000+38.8% | Added |
| Northern Trust Corp | 117,654 | $81.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 124,056 | $86.0K | 0.00% | −17,573−12.4% | Reduced |
| Susquehanna International Group, LLP | 164,155 | $113.0K | 0.00% | +38,862+31.0% | Added |
| State Street Corp | 176,494 | $122.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 246,191 | $170.0K | 0.00% | −358,827−59.3% | Reduced |
| Bank of America Corp | 393,307 | $271.0K | 0.00% | +189,121+92.6% | Added |
| Morgan Stanley | 564,462 | $390.0K | 0.00% | +64,837+13.0% | Added |
| Geode Capital Management, LLC | 670,747 | $463.0K | 0.00% | +81,551+13.8% | Added |
| Ikarian Capital, LLC | 1,228,416 | $849.0K | 0.19% | −17,573−1.4% | Reduced |
| Asymmetry Capital Management, L.P. | 1,401,491 | $968.0K | 0.58% | −49,286−3.4% | Reduced |
| Sarissa Capital Management LP | 1,851,851 | $1.28M | 0.10% | 00.0% | Unchanged |
| Victory Capital Management Inc | 2,227,212 | $1.54M | 0.00% | −10,730−0.5% | Reduced |
| Vanguard Group Inc | 3,105,045 | $2.15M | 0.00% | +9,808+0.3% | Added |
| Endurant Capital Management LP | 3,547,208 | $2.45M | 0.74% | +939,534+36.0% | Added |
| NEA Management Company, LLC | 6,451,056 | $4.46M | 0.06% | 00.0% | Unchanged |
| Focused Wealth Management, Inc | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −91,872−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −79,193−100.0% | Sold out |
| Strategic Wealth Advisors Group, LLC | 0 | $0 | 0.00% | −74,800−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −59,432−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −37,741−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −28,346−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −22,300−100.0% | Sold out |
| Endurance Wealth Management, Inc. | 0 | $0 | 0.00% | −6,750−100.0% | Sold out |